Minimal Inhibitory Concentration (MIC) and susceptibility profile of <i>C</i>.<i>krusei</i> clinical isolates.

CK, Candida krusei; S, susceptible; SDD, susceptible dose dependent; R, resistant; 5-FC, 5-flucytosine, MIC break point: S, ≤4 μg/ml; SDD, 8–16 μg/ml; R, ≥32 μg/ml; AMB, Amphotericin B, MIC break point: S, ≤1 μg/ml; SDD,2 μg/ml; R, >2 μg/ml; FLC, Fluconazole, MIC break point: S, ≤8 μg/ml; SDD, 16–32 μg/ml; R, ≥ 64 μg/ml; ITR, itraconazole, MIC break point: S, ≤0.125 μg/ml; SDD, 0.25–0.5 μg/ml; R, ≥ 1 μg/ml; VRC, voriconazole, MIC break point: S, ≤0.5 μg/ml; SDD,1 μg/ml; R, ≥2 μg/ml Minimal Inhibitory Concentration (MIC) and susceptibility profile of C.krusei clinical isolates.